NINDS Cooperative Program in Translational Research Funding Opportunities

Funding for Therapeutics Development Projects

• NINDS Exploratory/Developmental Projects in Translational Research for Resistant Epilepsy and Epileptogenesis (R21)- Funding for pilot projects to generate tools and proof-of-principle for therapeutics development in resistant epilepsy and epileptogenesis.

  http://grants.nih.gov/grants/guide/pa-files/PAR-10-143.html

• NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01)- Funding for full-scale single component research projects directed at developing new therapies for resistant epilepsy and epileptogenesis.

  http://grants.nih.gov/grants/guide/pa-files/PAR-11-154.html

• NINDS Cooperative Program in Translational Research (U01).  The milestone-driven program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND), Investigational Device Exemption (IDE), 510(k), or 510(k) de novo application to the Food and Drug Administration (FDA) can be submitted during the project period.
  http://grants.nih.gov/grants/guide/PA-files/PAR-13-022.htm

• NINDS Exploratory/Developmental Projects in Translational Research (R21).  Funding  to support any research activities required to advance development of candidate therapeutics (drugs, devices, and biologics).  Projects can be supported prior to or in parallel with cooperative agreement funding.
  http://grants.nih.gov/grants/guide/pa-files/PAR-13-023.html

Guidance and Resources for Therapeutics Development Projects

• Developing Milestones for NINDS Translational Research Cooperative Agreement Applications

• Resources for Scientists

  • Production Assistance for Cellular Therapies (PACT)